GLP-1 RAs tied to greater risk of diabetic retinopathy progression than SGLT-2is: study

July 31, 2024 Health Trends, Health Trends - Australia

In patients with diabetes and established diabetic retinopathy, treatment with GLP-1 receptor agonists is associated with increased risks of diabetic retinopathy progression compared with SGLT-2 inhibitors, according to a study in Diabetes, Obesity and Metabolism.

Researchers in Taiwan…

Source link

A note to our visitors

This website has updated its privacy policy in compliance with changes to European Union data protection law, for all members globally. We’ve also updated our Privacy Policy to give you more information about your rights and responsibilities with respect to your privacy and personal information. Please read this to review the updates about which cookies we use and what information we collect on our site. By continuing to use this site, you are agreeing to our updated privacy policy.

GLP-1 RAs tied to greater risk of diabetic retinopathy progression than SGLT-2is: study

Recent Posts

Recent Comments